Nigel Bundred

Professor of Surgical Oncology

The University of Manchester

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Cancer Biology Cancer Biology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Nigel Bundred is a Professor of Surgical Oncology at the University of Manchester, UK. His research focuses on breast cancer, particularly in the areas of lymphoedema prevention, surgical outcomes, and the efficacy of novel therapies such as lapatinib and trastuzumab. Recent publications highlight findings from systematic reviews and randomized controlled trials aimed at improving patient care in breast cancer treatment.

Articles (10)

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (5)

David Dodwell

University of Oxford

UNITED KINGDOM

View details

Robert Clarke

The University of Manchester

UNITED KINGDOM

View details

Mary Pegington

The University of Manchester

UNITED KINGDOM

View details

Adrian Murray Brunt

Professor of Clinical Oncology

Keele University School of Medicine

UNITED KINGDOM

View details

Abeer Shaaban

Professor (Hon)

University of Birmingham

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Nigel Bundred

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Prevention of lymphoedema after axillary clearance by external compression sleeves PLACE randomised trial results. Effects of high BMI

Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results

Randomised controlled trial of intermittent vs continuous energy restriction during chemotherapy for early breast cancer

Margin status and survival outcomes after breast cancer conservation surgery: prospectively registered systematic review and meta-analysis

FAK inhibition alone or in combination with adjuvant therapies reduces cancer stem cell activity

Prognostic and Predictive Value of HER2 Expression in Ductal Carcinoma In Situ: Results from the UK/ANZ DCIS Randomized Trial

Prognostic Value of ER and PgR Expression and the Impact of Multi-clonal Expression for Recurrence in Ductal Carcinoma in situ: Results from the UK/ANZ DCIS Trial

Reply to “Comment on: Increases in arm volume predict lymphoedema and quality of life deficits after axillary surgery: a prospective cohort study”

Increases in arm volume predict lymphoedema and quality of life deficits after axillary surgery: a prospective cohort study

Breast cancer stromal clotting activation (Tissue Factor and thrombin): A pre‐invasive phenomena that is prognostic in invasion

Collaborators (5)

David Dodwell

Robert Clarke

Mary Pegington

Adrian Murray Brunt

Abeer Shaaban

Make your next move.